Medicus Pharma Stock (NASDAQ:MDCX)

Financials Chart

Previous Close

$1.37

52W Range

$1.14 - $8.94

50D Avg

$1.78

200D Avg

$2.74

Market Cap

$30.39M

Avg Vol (3M)

$307.27K

Beta

-1.73

Div Yield

-

MDCX Company Profile

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

12

IPO Date

Nov 15, 2024

Website

MDCX Performance

MDCX Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-11.18M	$-4.73M	$-978.42K
Net Income	$-10.62M	$-5.31M	$-1.69M
EBITDA	$-10.25M	$-2.66M	$-1.17M
Basic EPS	$-1.10	$-1.53	$-0.88
Diluted EPS	$-1.10	$-1.53	$-0.21

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

Ticker	Company
SKYE	Skye Bioscience, Inc.
COEP	Coeptis Therapeutics, Inc.
CUE	Cue Biopharma, Inc.
INMB	INmune Bio, Inc.
IPSC	Century Therapeutics, Inc.
BRNS	Barinthus Biotherapeutics plc
TELO	Telomir Pharmaceuticals, Inc. Common Stock
KPTI	Karyopharm Therapeutics Inc.
ALGS	Aligos Therapeutics, Inc.